Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James G Xenakis

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Archives of Internal Medicine|October 13, 2006
Ignoring study design heterogeneity in meta-analysesJ Jaime Caro, James G Xenakis, Krista F Huybrechts
Medical Care|July 6, 2021
Methodological Challenges and Statistical Approaches in the COMprehensive Post-Acute Stroke Services StudyMatthew A Psioda, Sara B Jones, James G Xenakis, et al.
The Annals of Applied Statistics|July 16, 2025
A DEEP NEURAL NETWORK TWO-PART MODEL AND FEATURE IMPORTANCE TEST FOR SEMI-CONTINUOUS DATABaiming Zou, Xinlei Mi, Shiyu Wan, et al.
Briefings in Bioinformatics|January 16, 2025
A deep learning feature importance test framework for integrating informative high-dimensional biomarkers to improve disease outcome predictionBaiming Zou, James G Xenakis, Meisheng Xiao, et al.
Current Medical Research and Opinion|November 2, 2006
Budgetary impact of treating acute bipolar mania in hospitalized patients with quetiapine: an economic analysis of clinical trialsJ Jaime Caro, Krista F Huybrechts, James G Xenakis, et al.
Plos One|June 13, 2022
A mixed-effects two-part model for twin-data and an application on identifying important factors associated with extremely preterm children's health disordersBaiming Zou, Hudson P Santos, James G Xenakis, et al.
Epilepsia|November 3, 2020
Gabra2 is a genetic modifier of Scn8a encephalopathy in the mouseWenxi Yu, Sophie F Hill, James G Xenakis, et al.
Pharmacoeconomics|July 4, 2013
Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventionsDenis Getsios, Jenő P Marton, Nikhil Revankar, et al.
Pharmacoeconomics|April 2, 2011
A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial dataJames G Xenakis, Elizabeth T Kinter, K Jack Ishak, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Large differences in collateral blood vessel abundance among individuals arise from multiple genetic variantsJames E Faber, Hua Zhang, James G Xenakis, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Archives of Internal Medicine|October 13, 2006
Ignoring study design heterogeneity in meta-analysesJ Jaime Caro, James G Xenakis, Krista F Huybrechts
Medical Care|July 6, 2021
Methodological Challenges and Statistical Approaches in the COMprehensive Post-Acute Stroke Services StudyMatthew A Psioda, Sara B Jones, James G Xenakis, et al.
The Annals of Applied Statistics|July 16, 2025
A DEEP NEURAL NETWORK TWO-PART MODEL AND FEATURE IMPORTANCE TEST FOR SEMI-CONTINUOUS DATABaiming Zou, Xinlei Mi, Shiyu Wan, et al.
Briefings in Bioinformatics|January 16, 2025
A deep learning feature importance test framework for integrating informative high-dimensional biomarkers to improve disease outcome predictionBaiming Zou, James G Xenakis, Meisheng Xiao, et al.
Current Medical Research and Opinion|November 2, 2006
Budgetary impact of treating acute bipolar mania in hospitalized patients with quetiapine: an economic analysis of clinical trialsJ Jaime Caro, Krista F Huybrechts, James G Xenakis, et al.
Plos One|June 13, 2022
A mixed-effects two-part model for twin-data and an application on identifying important factors associated with extremely preterm children's health disordersBaiming Zou, Hudson P Santos, James G Xenakis, et al.
Epilepsia|November 3, 2020
Gabra2 is a genetic modifier of Scn8a encephalopathy in the mouseWenxi Yu, Sophie F Hill, James G Xenakis, et al.
Pharmacoeconomics|July 4, 2013
Smoking cessation treatment and outcomes patterns simulation: a new framework for evaluating the potential health and economic impact of smoking cessation interventionsDenis Getsios, Jenő P Marton, Nikhil Revankar, et al.
Pharmacoeconomics|April 2, 2011
A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial dataJames G Xenakis, Elizabeth T Kinter, K Jack Ishak, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Large differences in collateral blood vessel abundance among individuals arise from multiple genetic variantsJames E Faber, Hua Zhang, James G Xenakis, et al.
Pageof 2